| (CNY) | Dec 2024 | Y/Y change |
|---|---|---|
| Revenue | 1.59B | -0.27% |
| Operating expense | — | — |
| Net income | 100.35M | -5.73% |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, 600645.SS returned -29.7% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | -20.5% |
| 1 year | -29.7% |
| 5 years | -2.2% |
| 10 years | -45.2% |
| All-time high | ¥79.34 (Sep 2015) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what ¥1,000 in 600645.SS would be worth today ›No. Vcanbio Cell & Gene Engineering Corp., Ltd has not paid a dividend in the past 12 months.
Vcanbio Cell & Gene Engineering Corp., Ltd is part of the Healthcare sector.
Vcanbio Cell & Gene Engineering Corp., Ltd has a market cap of 9.00B CNY, based on the latest quote.
